GKOS Glaukos Corporation
798
$108.08
$0.46
(0.43%)
| Watchers | 798 |
| 52-Wk Low | $54.38 |
| 52-Wk High | $110.73 |
| Market Cap | $5.42B |
| Volume | 35,667.00 |
| 52-Wk High | $110.73 |
| 52-Wk Low | $54.38 |
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' AnalystBenzinga • 8 days ago
Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%.
Latest Ratings for GKOS
DateFirmActionFromTo Feb...
Share to Feed
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans...
Glaukos Co. (NYSE:GKOS - Get Free Report) CFO Alex R. Thurman sold 434 shares of the stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $95.33...
Glaukos Corporation's ( NYSE:GKOS ) price-to-sales (or "P/S") ratio of 14.8x might make it look like a strong sell...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today...
Glaukos (NYSE:GKOS - Get Free Report)s stock had its "buy" rating reissued by analysts at Stifel Nicolaus in a note issued to investors on Wednesday, Benzinga reports. They presently have a...
This is a signal that GKOS's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...